Arthritis Therapeutics Market to Gain Momentum, Fuelled by High Adoption of Biologics, Finds Fact.MR

Weighing the impact of key influencers, a recent report published by Fact.MR infers that, the arthritis therapeutics market is estimated to grow 1.5X during the forecast period (2020 - 2027).

Rockville, United States - December 6, 2019 /MarketersMedia/ —

Rapid emergence of biologics presents new commercial opportunities for players in the arthritis therapeutics market. The adoption of biologic drugs is high, especially in developed countries of North America, Europe, and Asia Pacific, given the influence of favourable reimbursement scenarios that cushion the high cost.

In North America and Europe, the presence of public and private medical insurance plans encourages patients to avail quality healthcare. However, in developing countries of Asia Pacific, the out-of-pocket payment model is dominant in the healthcare industry, which is leading to sluggish growth of the arthritis therapeutics market in India and China. In addition, the penetration of generic drugs is high in developing countries of Asia Pacific, owing to their competitive prices.

A comprehensive study published by Fact.MR projects the arthritis therapeutics market to register 7.3% growth in 2020, over 2019.

Request Sample Report-

Key Takeaways of Arthritis Therapeutics Market Study

- Constant rise in the prices of popular drugs such as Humira and Enbrel could shift the focus of patients towards complementary and alternative therapies, thereby narrowing the growth of the arthritis therapeutics market. The impact of this trend will be relatively high in developing countries of Asia Pacific such as India and China, as these regions are characterized by high inclination towards natural and herbal therapies.

- Patent expiration of blockbuster drugs in the arthritis therapeutics market are pushing manufacturers to increase investments towards the development of effective drugs, which is projected to fuel the advancements of biosimilar products.
High precision of drugs offered by arthritis therapeutics is projected to maintain patients’ inclination towards parenteral route of administration during the forecast period.

- In 2020, retail pharmacies are projected to account for 79% of the total sales of arthritis therapeutics, as the high concentration of this channels across key locations makes it convenient for patients to purchase the required drugs. However, sales through online pharmacies will gain traction, owing to attractive discounts and convenience offered.

A key opinion leader at Fact.MR portends, “Demand for interleukin inhibitors is outperforming TNF inhibitors in terms of efficacy. In future, with effective marketing efforts by manufacturers, patients will turn more receptive to these novel biologic products.”

Request Research Methodology-

R&D Remains Key Strength of Global Players; Regional Players Excel through Robust Distribution Networks

The arthritis therapeutics market, characterized by consolidation, is dominated by AbbVie Inc., Johnson & Johnson, Amgen Inc., and Novartis Inc. Development of blockbuster drugs enables these leading players to gain an edge over regional and local players. For instance, 33% of share in the arthritis therapeutics market accounted by AbbVie is attributable to its flagship product - Humira, which recorded sales corresponding to a value of US$ 20 Bn in 2018.

On similar lines, Johnson & Johnson strives to diversify its product portfolio through the introduction of effective therapeutics. The company is highly recognized for the launch of Simponi, Tremfya, and Stelara. Distribution channels remain the key strength of regional players. For instance, Eli Lily and Company offers most of its products around the world, and executes effective marketing strategies to position its products in various countries to meet unmet local needs.

Have Any Query? Ask Our Analysts-

Find More Valuable Insights on Arthritis Therapeutics Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global arthritis therapeutics market, presenting historical demand data (2017-2019), and forecast statistics for the period of 2020-2027. The study divulges compelling insights on the arthritis therapeutics market on the basis of type (rheumatoid arthritis, gout, psoriatic arthritis, osteoarthritis, and others), drug class (TNF inhibitors, interleukin inhibitors, NSAIDs, corticosteroids, xanthine oxidase inhibitors, and others), route of administration (parenteral, topical, and oral), and distribution channel (online pharmacies, hospital pharmacies, and retail pharmacies), across five major regions.

To Get more information on Arthritis Therapeutics Market, visit-

About the Healthcare Division at Fact.MR

The healthcare team at Fact.MR assists clients with unique business intelligence needs on a global level. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the healthcare industry to a micro-level across 50+ countries for over a decade. The team provides end-to-end research and consulting services to help keep clients at the top of the game. Reach out to us to know how we can help.

Contact Info:
Name: James Hilton
Email: Send Email
Organization: Fact.MR

Source URL:

Source: MarketersMedia

Release ID: 88937926

More News From Daily Tech Geek

Climate activist: Why tout development if there's no future?

Jan 27, 2020

NEW DELHI — An Indian girl who was among the 16 young activists filing a complaint at the United Nations accusing countries of inaction on climate change has taken that step before. Ridhima Pandey, now 11, filed a petition in 2017 at India's National Green Tribunal, which oversees environmental concerns, for not taking serious enough steps to combat climate change. It was dismissed, but she escalated it to the Indian Supreme Court. Pandey was among the activists including Swedish teen Greta Thunberg who criticized Germany, France, Brazil, Argentina and Turkey for failing to uphold their obligations to young people under...

Pakistan battles dengue epidemic, with 20 deaths so far

Jan 27, 2020

ISLAMABAD — Pakistani health officials were battling an outbreak of dengue fever in the South Asian nation on Tuesday, a day after health officials confirmed over 10,000 cases and 20 deaths in recent months. More patients with symptoms of dengue fever were arriving at hospitals in all major cities, including the capital Islamabad, putting a strain on the country's poor health system. Health officials hope that the anti-mosquito spraying in urban areas targeting stagnant water will help contain the disease. According to Zafar Mirza, a government adviser on health, as many as 10,013 dengue cases had so far been reported....

Over 30 Indian worshippers drown during Hindu rituals

Jan 27, 2020

NEW DELHI — More than 30 Hindu worshippers have drowned in swollen rivers and in a lake in India as thousands participated in religious ceremonies in which figures of a Hindu god are immersed in water, officials and news reports said Friday. At least 11 people drowned when their boat capsized early Friday on a lake in central India, rescuers said. Six people were able to swim ashore in the lake in Bhopal, the capital of Madhya Pradesh state, and a search was on for one missing person, said National Disaster Response Force spokesman Krishan Kumar. Kumar said 11 bodies...

India loses communication with its unmanned moon lander

Jan 27, 2020

NEW DELHI — India's space agency said it lost touch Saturday with its Vikram lunar lander as it aimed to land on the south pole of the moon and deploy a rover to search for signs of water. The space agency was analyzing data as it worked to determine what had happened. "Communications from lander to ground station was lost," said K Sivan, chairman of the Indian Space Research Organisation. "The data is being analysed." A successful landing would have made India just the fourth country to land a vessel on the lunar surface, and only the third nation to...

Protest in Nepal against plan to cut trees to widen road

Jan 27, 2020

KATHMANDU, Nepal — More than 200 people rallied in Nepal's capital Thursday to protest government plans to cut down about 2,000 trees to widen a key road that circles the city. The protesters held signs urging the government to stop the plan to remove the trees on the outer edge of Kathmandu. The 27-kilometer (17-mile) Ring Road encircles the capital and is a key road network for the increasingly congested city. "These trees were controlling pollution and giving fresh air so they cannot be cut down to make roads," said Saurav Dhakal, a protester. "Kathmandu is suffering from massive air...

About Us

Daily Tech Geek delivers Technology news only covering the multiple fields in the industry.

Contact us: sales[at]

Subscribe Now!